Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts1
Open Access
- 1 January 2007
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 9 (1), 20-28
- https://doi.org/10.1215/15228517-2006-016
Abstract
Despite multimodal treatment options, the response and survival rates for patients with malignant gliomas remain dismal. Clinical trials with convectKeywords
This publication has 40 references indexed in Scilit:
- Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model1Neuro-Oncology, 2006
- Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agentsJournal of Neurosurgery, 2005
- Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brainExperimental Neurology, 2005
- Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignanciesGynecologic Oncology, 2004
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase FunctionJournal of Biological Chemistry, 2002
- The blood-brain and blood-tumor barriers: A review of strategies for increasing drug deliveryNeuro-Oncology, 2000
- Pharmacokinetics and anti‐tumor activity of vincristine encapsulated in sterically stabilized liposomesInternational Journal of Cancer, 1995
- Topoisomerase InhibitorsDrugs, 1995
- Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude miceInternational Journal of Cancer, 1992